References
- Laumann E, Paik A, Rosen R. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999;281:537–44
- Aslan E, Fynes M. Female sexual dysfunction. Int Urogynecol J Pelvic Floor Dysfunct 2008;19:293–305
- Basson R, Althof S, Davis S, et al. Summary of the recommendations on sexual dysfunctions in women. J Sex Med 2004;1:24–34
- Laumann EO, Nicolosi A, Glasser DB, et al. Sexual problems among women and men aged 40-80 y: prevalence and correlates identified in the global study of sexual attitudes and behaviors. Int J Impot Res 2005;17:39–57
- American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders. 4th ed. Washington, D.C.: American Psychiatric Association; 1994
- Basson R, Leiblum S, Brotto L, et al. Definitions of women’s sexual dysfunctions reconsidered: advocating expansion and revision. J Psychosom Obstet Gynaecol 2003;24:221–9
- Berman JR. Physiology of female sexual function and dysfunction. Int J Impot Res 2005;17:44–51
- James GP. Pathways of sexual desire. J Sex Med 2009;6:1506–33
- Davis SR, Davison SL, Donath S, Bell RJ. Circulating androgen levels and self-reported sexual function in women. JAMA 2005;294:91–6
- Berman JR, Almeida FG, Jolin J, et al. Correlation of androgen receptors, aromatase, and 5-alpha reductase in the human vagina with menopausal status. Fertil Steril 2003;79:925–31
- Bolour S, Braunstein G. Testosterone therapy in women: a review. Int J Impot Res 2005;17:399–408
- De Gendt K, Verhoeven G. Tissue and cell-specific functions of the androgen receptor revealed through conditional knockout models in mice. Mol Cell Endocrinol 2012;352:13–25
- Shifren JL, Davis SR, Moreau M, et al. Testosterone patch for the treatment of hypoactive sexual desire disorder in 57 naturally menopausal women: results from the INTIMATE NM1 Study. Menopause 2006;13:770–9
- Egli M, Leeners B, Kruger TH. Prolactin secretion patterns: basic mechanisms and clinical implications for reproduction. Reproduction 2010;140:643–54
- Brenta G, Schnitman M, Gurfinkiel M, et al. Variations of sex hormone-binding globulin in thyroid dysfunction. Thyroid 1999;9:273–7
- Sowers M, Luborsky J, Perdue C, et al. Thyroid stimulating hormone (TSH) concentrations and menopausal status in women at the mid-life: SWAN. Clin Endocrinol (Oxf) 2003;58:340–7
- Rosen R, Brown C, Heiman J, et al. The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000;26:191–208
- Wallach J. Interpretation of diagnostic test. 9th ed. Philadelphia, Pennsylvania: Lippincott Williams & Wilkins; 2011
- Leiblum SR, Koochaki PE, Rodenberg CA, et al. Hypoactive sexual desire disorder in postmenopausal women: U.S. results from the women's international study of health and sexuality (WISHeS). Menopause 2006;13:46–56
- Ben-Jonathan N, Mershon JL, Allen DL, Steinmetz RW. Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev 1996;17:639–69
- Lerant AA, DeMaria JE, Freeman ME. Decreased expression of fos-related antigens (FRAs) in the hypothalamic dopaminergic neurons after immunoneutralization of endogenous prolactin. Endocrine 2001;16:181
- Gillam MP, Molitch ME, Lombardi G, Colao A. Advances in the treatment of prolactinomas. Endocr Rev 2006;27:485–534
- Atis G, Dalkilinc A, Altuntas Y, et al. Sexual dysfunction in women with clinical hypothyroidism and subclinical hypothyroidism. J Sex Med 2010;7:2583–90